GO:0005899 insulin receptor complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005899 (insulin receptor complex) is a disulfide-bonded heterotetrameric receptor complex in which the alpha chains are entirely extracellular and each beta chain contains one transmembrane domain and an intracellular kinase domain.
• The insulin receptor complex is the primary cellular sensor for insulin and related ligands, coupling extracellular ligand binding to intracellular tyrosine kinase signaling.
• Structural studies by cryo-EM and X-ray crystallography have revealed the architecture of the insulin receptor-insulin complex, including the ligand-binding site and the conformational changes that accompany activation.
• Alternative splicing of INSR generates two major isoforms (IR-A and IR-B) with distinct ligand-binding and signaling properties that are relevant to cancer and metabolic disease.
• The insulin receptor complex interacts with accessory proteins such as dystrophin glycoprotein complex components and plakoglobin to regulate muscle size and signaling.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of insulin receptor complex function in health and disease.
Description
The insulin receptor complex (GO:0005899) is a specialized cell-surface receptor assembly that mediates the cellular response to insulin and insulin-like ligands. It is a disulfide-bonded heterotetramer composed of two extracellular alpha chains and two transmembrane beta chains, with the ligand-binding site located on the alpha subunits and tyrosine kinase activity residing in the intracellular portion of the beta subunits. Because insulin signaling controls glucose uptake, metabolism, growth, and survival, the insulin receptor complex is central to metabolic physiology and is implicated in diabetes, cancer, and muscle-wasting conditions. Understanding its structure, assembly, and regulation is therefore a major goal in biomedical research. The insulin receptor complex has been studied for decades, yet recent advances in cryo-electron microscopy and single-particle analysis have provided near-atomic resolution views of the receptor bound to insulin, clarifying how ligand binding triggers activation. These structural insights, combined with genetic and cell-biology approaches, have made GO:0005899 a model system for receptor tyrosine kinase signaling and a target for therapeutic development.
insulin receptor complex At A Glance
| GO ID | GO:0005899 |
|---|---|
| GO term | insulin receptor complex |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Ligand-activated tyrosine kinase signaling in response to insulin and related ligands |
| Subunit composition | Heterotetramer of two alpha and two beta chains linked by disulfide bonds |
| Ligand-binding site | Extracellular alpha subunit domain |
| Kinase domain | Intracellular beta subunit domain |
| Transmembrane topology | Each beta chain contains one transmembrane domain |
What Is GO:0005899?
According to the Gene Ontology, GO:0005899 (insulin receptor complex) is defined as a disulfide-bonded, heterotetrameric receptor complex. The alpha chains are entirely extracellular, while each beta chain has one transmembrane domain. The ligand binds to the alpha subunit extracellular domain and the kinase is associated with the beta subunit intracellular domain. In other words, it is a four-subunit receptor in which two extracellular alpha subunits and two membrane-spanning beta subunits are linked by disulfide bonds, forming a functional unit that binds insulin outside the cell and transmits signals inside the cell.
Why Is insulin receptor complex Important in Cell Biology?
The insulin receptor complex is essential for normal glucose homeostasis, growth, and metabolism, and its dysfunction is linked to major human diseases including diabetes, cancer, and muscle atrophy. Because it is the primary receptor for insulin, understanding its structure and regulation is critical for developing therapeutics that modulate insulin signaling.
• Mediates insulin-stimulated glucose uptake and metabolic regulation.
• Serves as a model system for receptor tyrosine kinase activation and signaling.
• Alternative splicing produces IR-A and IR-B isoforms with distinct roles in cancer and metabolism.
• Interacts with the dystrophin glycoprotein complex and plakoglobin to regulate muscle size.
• Dysregulation is associated with insulin resistance, diabetes, and cancer progression.
• Provides a target for therapeutic antibodies and small molecules in metabolic disease.
• Its gene expression is subject to complex enhancer regulation.
• Structural knowledge enables rational design of insulin analogs and receptor modulators.
Structure and Composition of insulin receptor complex
Heterotetrameric architecture
In simple terms: The insulin receptor is made of four parts: two outside the cell and two that cross the cell membrane.
The insulin receptor complex is a disulfide-bonded heterotetramer composed of two alpha chains and two beta chains. The alpha chains are entirely extracellular, while each beta chain contains a single transmembrane domain and an intracellular tyrosine kinase domain. This arrangement places the ligand-binding site on the alpha subunits and the catalytic kinase on the beta subunits.
Ligand binding and conformational change
In simple terms: Insulin binds to the outside part of the receptor and causes the receptor to change shape and activate.
Insulin binds to the extracellular alpha subunit domain, inducing conformational changes that are transmitted to the intracellular beta subunit kinase domains. Cryo-EM structures of the insulin receptor-insulin complex have revealed the detailed binding interface and the structural rearrangements that accompany activation.
Kinase activation and autophosphorylation
In simple terms: Once insulin binds, the inside parts of the receptor add phosphate groups to each other to turn on signaling.
Ligand binding activates the intrinsic tyrosine kinase activity of the beta subunits, leading to autophosphorylation of the receptor and subsequent phosphorylation of substrate proteins. This kinase activity is associated with the beta subunit intracellular domain.
Interaction with accessory proteins
In simple terms: The receptor does not work alone; it teams up with other proteins to control cell functions.
The insulin receptor complex forms a signaling hub with proteins such as dystrophin glycoprotein complex components and plakoglobin, which together regulate muscle size. These interactions expand the functional repertoire of the receptor beyond canonical insulin signaling.
Isoforms and splice variants
In simple terms: The receptor comes in two slightly different versions that behave differently in cells.
Alternative splicing of the INSR gene generates two major isoforms, IR-A and IR-B, which differ in ligand binding and signaling properties and have distinct roles in cancer and metabolic tissues. These isoforms add another layer of complexity to the study of the insulin receptor complex.
Key Genes Involved in GO:0005899 insulin receptor complex
The following genes and proteins are central to the structure, regulation, and function of the insulin receptor complex (GO:0005899).
| Gene | Major Role | Research Relevance |
|---|---|---|
| INSR | Encodes the insulin receptor alpha and beta chains | Core component of GO:0005899; mutations cause insulin resistance syndromes |
| INS | Insulin ligand that binds the receptor | Ligand for the insulin receptor complex; structural studies |
| IGF1 | Insulin-like growth factor 1 | Cross-reacts with insulin receptor isoforms; relevant to growth and cancer |
| IGF2 | Insulin-like growth factor 2 | Binds IR-A with high affinity; implicated in cancer |
| IRS1 | Insulin receptor substrate 1 | Docking protein phosphorylated by the receptor kinase |
| IRS2 | Insulin receptor substrate 2 | Mediates metabolic signaling downstream of the receptor |
| PIK3CA | PI3-kinase catalytic subunit | Downstream effector of insulin receptor signaling |
| AKT1 | Serine/threonine kinase | Key downstream node in insulin signaling |
| DMD | Dystrophin | Component of dystrophin glycoprotein complex interacting with insulin receptor |
| JUP | Plakoglobin | Part of the signaling hub with insulin receptor and DGC |
| SGCA | Sarcoglycan alpha | Dystrophin glycoprotein complex component |
| SNTB1 | Beta-1 syntrophin | Links DGC to signaling proteins |
| PTPN1 | Protein tyrosine phosphatase 1B | Negative regulator of insulin receptor phosphorylation |
| GRB2 | Adaptor protein | Couples receptor to Ras-MAPK pathway |
| SHC1 | Adaptor protein | Phosphorylated by insulin receptor; activates MAPK |
| SLC2A4 | GLUT4 glucose transporter | Translocates to membrane upon insulin receptor activation |
| FOXO1 | Forkhead transcription factor | Regulated by insulin signaling; controls gluconeogenesis |
| Ecdysone receptor | Nuclear receptor | Long-range repression of insulin receptor gene in Drosophila |
How Is insulin receptor complex Regulated?
The insulin receptor complex is regulated at multiple levels. Its gene expression is controlled by complex enhancers, including long-range repression by the ecdysone receptor in Drosophila. Post-translational regulation includes autophosphorylation and dephosphorylation by phosphatases such as PTPN1. Ligand availability, receptor isoform splicing, and interaction with accessory proteins like dystrophin glycoprotein complex components further modulate signaling output.
insulin receptor complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INSR | Insulin resistance, diabetes | Knockout or point-mutation cell lines; patient-derived iPSCs |
| INSR (IR-A) | Cancer proliferation | Overexpression in cancer cell lines; isoform-specific knock-in |
| DMD | Duchenne muscular dystrophy | Dystrophin knockout muscle cells; co-culture with insulin receptor mutants |
| JUP | Muscle size regulation | Plakoglobin knockout or knockdown in muscle cells |
| PTPN1 | Insulin resistance | PTPN1 knockout or overexpression in metabolic cell models |
Insulin resistance and diabetes
Dysfunctional insulin receptor signaling is a hallmark of type 2 diabetes and insulin resistance. Mutations in INSR can cause severe insulin resistance syndromes, and impaired receptor kinase activity contributes to metabolic disease.
Cancer
The IR-A isoform is frequently overexpressed in cancer and can drive proliferation and survival, making the insulin receptor complex a potential therapeutic target. IGF2 binding to IR-A further promotes oncogenic signaling.
Muscle wasting and neuromuscular disease
The insulin receptor complex interacts with the dystrophin glycoprotein complex and plakoglobin to regulate muscle size, linking it to muscle-wasting conditions and neuromuscular disorders.
From insulin receptor complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of INSR abolish insulin signaling? | INSR knockout cell line (e.g., HEK293, HepG2) |
| How do point mutations in the kinase domain affect activity? | Point-mutation knock-in of INSR kinase domain |
| What is the role of IR-A versus IR-B in cancer? | Isoform-specific knock-in or overexpression |
| How does the receptor interact with DGC components? | Tagged knock-in of INSR and DGC subunits for co-IP |
| Can overexpression of INSR drive metabolic phenotypes? | Overexpression of wild-type or mutant INSR in cell lines |
| How is INSR gene expression regulated by enhancers? | CRISPR interference or knockout of enhancer elements |
How to Study the insulin receptor complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of receptor-ligand complex | Visualizing insulin binding and activation |
| Western blot | Phosphorylation of IR and downstream targets | Assessing insulin signaling activation |
| CRISPR knockout | Loss-of-function phenotype | Testing necessity of INSR or interacting genes |
| CRISPR knock-in | Precise mutation or tag insertion | Studying point mutations or tagged receptor |
| Co-immunoprecipitation | Protein-protein interactions | Identifying DGC and plakoglobin association |
| RNA-seq | Transcriptional changes | Measuring insulin-responsive gene expression |
| Glucose uptake assay | Functional glucose transport | Evaluating insulin sensitivity in cell models |
| Proximity ligation assay | In situ protein interactions | Detecting receptor complex components in cells |
Structural biology (cryo-EM and crystallography)
Cryo-electron microscopy and X-ray crystallography have been used to determine the three-dimensional structure of the insulin receptor-insulin complex, revealing the ligand-binding site and activation mechanism.
Cell signaling assays
Western blotting for phospho-insulin receptor and downstream effectors (AKT, MAPK) is standard for measuring insulin receptor complex activity.
Genetic manipulation with CRISPR
CRISPR-Cas9 knockout, point mutation, and knock-in approaches enable precise dissection of INSR and interacting genes in cell models.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry can identify proteins associated with the insulin receptor complex, such as dystrophin glycoprotein complex components.
How CRISPR Can Be Used to Study GO:0005899 insulin receptor complex
Knockout
CRISPR knockout of INSR or interacting genes (e.g., DMD, JUP) can abolish insulin receptor complex function and reveal its role in signaling and muscle size regulation.
Point Mutation
Point mutations in the INSR kinase domain or ligand-binding domain can be introduced to model insulin resistance syndromes and to dissect structure-function relationships.
Knock-in
Knock-in of tagged INSR (e.g., GFP or HA) allows visualization and purification of the receptor complex, while isoform-specific knock-in (IR-A or IR-B) enables studies of isoform-specific functions.
Overexpression
Overexpression of wild-type or mutant INSR in cell lines can drive insulin-independent signaling and is used to study oncogenic potential of the receptor.
How EDITGENE Supports insulin receptor complex Research
Researchers studying insulin receptor complex-related genes often need to determine whether a candidate gene is causally involved in receptor assembly, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable such studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for insulin receptor complex research.
Frequently Asked Questions About insulin receptor complex
What is the insulin receptor complex?
The insulin receptor complex (GO:0005899) is a disulfide-bonded heterotetrameric receptor complex that binds insulin and transmits signals into the cell via its intracellular tyrosine kinase domains.
What genes are involved in the insulin receptor complex?
The core gene is INSR, which encodes both alpha and beta chains; interacting genes include IRS1, IRS2, PIK3CA, AKT1, and DMD.
What is the structure of the insulin receptor complex?
It consists of two extracellular alpha chains and two transmembrane beta chains linked by disulfide bonds, with ligand binding on alpha and kinase activity on beta.
How does insulin activate the insulin receptor complex?
Insulin binds to the extracellular alpha subunits, inducing conformational changes that activate the intracellular beta subunit kinase domains, leading to autophosphorylation and downstream signaling.
What are the isoforms of the insulin receptor?
Alternative splicing of INSR produces IR-A and IR-B isoforms, which differ in ligand binding and are differentially expressed in cancer and metabolic tissues.
What diseases are associated with the insulin receptor complex?
Dysfunction is linked to insulin resistance, diabetes, cancer, and muscle-wasting conditions.
How can CRISPR be used to study the insulin receptor complex?
CRISPR knockout, point mutation, knock-in, and overexpression can be used to dissect the function of INSR and interacting genes in cell models.
What methods are used to study the insulin receptor complex?
Cryo-EM, Western blotting, co-immunoprecipitation, RNA-seq, and glucose uptake assays are commonly used.
What is the role of the insulin receptor complex in muscle?
It interacts with the dystrophin glycoprotein complex and plakoglobin to regulate muscle size.
How is the insulin receptor gene regulated?
INSR expression is controlled by complex enhancers, including long-range repression by the ecdysone receptor in Drosophila.
Conclusion
The insulin receptor complex (GO:0005899) is a fundamental signaling assembly that mediates insulin action and is implicated in metabolic and proliferative diseases. Advances in structural biology and CRISPR-based genetics continue to illuminate its mechanism and regulation. Targeting this complex holds promise for therapeutic intervention in diabetes, cancer, and muscle disorders.
References
- 1. Lawrence MC. 2021. Understanding insulin and its receptor from their three-dimensional structures.. Mol Metab 52:101255 PMID: 33992784
- 2. Eid Mutlak Y et al.. 2020. A signaling hub of insulin receptor, dystrophin glycoprotein complex and plakoglobin regulates muscle size.. Nat Commun 11(1):1381 PMID: 32170063
- 3. Scapin G et al.. 2018. Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis.. Nature 556(7699):122-125 PMID: 29512653
- 4. Vella V et al.. 2018. Insulin Receptor Isoforms in Cancer.. Int J Mol Sci 19(11) PMID: 30453495
- 5. Forbes BE. 2023. The three-dimensional structure of insulin and its receptor.. Vitam Horm 123:151-185 PMID: 37717984
- 6. Thompson KD et al.. 2023. Long-range repression by ecdysone receptor on complex enhancers of the insulin receptor gene.. Fly (Austin) 17(1):2242238 PMID: 37621079
- 7. Perz M et al.. 2001. Insulin receptor--structural and functional characteristics.. Med Sci Monit 7(1):169-77 PMID: 11208515
- 8. Lyen KR. 1985. The insulin receptor.. Ann Acad Med Singap 14(2):364-73 PMID: 2994544
